Amarin Corp. Plc (AMRN)
13.96
+0.44
(+3.29%)
USD |
NASDAQ |
Dec 31, 16:00
13.97
+0.02
(+0.11%)
After-Hours: 20:00
Amarin Cash from Investing (Quarterly): -12.29M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Trinity Biotech Plc | -1.996M |
| Jazz Pharmaceuticals Plc | -327.80M |
| DBV Technologies SA | -0.2404M |
| Cellectis SA | -3.266M |
| Akari Therapeutics Plc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.76M |
| Cash from Financing (Quarterly) | -0.24M |
| Free Cash Flow | -21.82M |
| Free Cash Flow Per Share (Quarterly) | -0.6143 |
| Free Cash Flow to Equity (Quarterly) | -12.16M |
| Free Cash Flow to Firm (Quarterly) | -12.76M |
| Free Cash Flow Yield | -1.32% |